AI Agents for Merger Models

For the Kenvue deal, please send over the below draft figures for pre-deal target multiples for FY24. Utilize potential median deal value Return to me a message with: Deal value/EBITDA, Deal value/EBIT, and Deal value/OpFCF. Round all values to one decimal place.

KVUE's cost of debt is updated to be the risk-free rate plus 100 basis points. Reply to me with KVUE's enterprise value, rounded to the nearest whole number in millions. Use the following situation to calculate the values: - Replace risk-free rate with the 10-year treasury rate as of 1/2/26 with beta at 0.75 - Replace risk-free rate with the 10-year treasury rate as of 1/2/26 with beta at 1.00 - Replace risk-free rate with the 30-year treasury rate as of 1/2/26 with beta at 0.75 - Replace risk-free rate with the 30-year treasury rate as of 1/2/26 with beta at 1.00

Update the base-case DCF model of KVUE with U.S. total equity risk premium of 4.33%, the risk free rate with the 5-Year Treasury rate and the KVUE Close share price on 2025-12-15. Let's measure the impact of an increase in tax rate by 4 percentage points (apply to 2025E-2029E and the WACC tax shield) and the decrease in terminal growth rate by 0.25 percentage points. Reply back to me, giving the updated enterprise value, equity value and implied share price, rounded to two decimal places. Express enterprise value and equity value in millions.

Use the DCF model, and make the following changes: - update net sales growth rate in 2029E to be the 2023A actual figure - update long-term growth rate to the 30-year treasury rate as of 1/2/26 minus 100 basis points Reply here with the terminal value. Round it to the nearest whole number in millions.

If you updated the long-term growth rate in the DCF model to be the percentage increase in CPI in 2025 from January 1, 2025 to November 1, 2025, what is the updated implied share price? Also, increase WACC by 60bps and update sales growth to 0.5% every year for the projection period to get your answer. Round it to two decimal places. Write out your answer here.

Please audit the financials of the smallest company in our Refined Comps table by market cap using only the IS, CFS, and BS from sec filings and data tools available to you. Report Adjusted EBITDA and EV in thousands of dollars. Report EV/EBITDA to two decimal points. Calculate the following, and report it back to me with a message here: - Adjusted TTM EBITDA including SBC addback - Adjusted TTM EBITDA excluding SBC addback - EV as of 12/17/25 (use basic weighted-average shares from the latest 10-Q and include all lease liabilities) - EV / adjusted TTM EBITDA (incl SBC) - EV / adjusted TTM EBITDA (excl SBC) Note: Adjusted EBITDA defined as operating income and cash-flow non-cash addbacks, excluding non-cash operating lease cost.

Reply back to me with the following values: - Implied share price. - Enterprise value - % weight of PV of terminal value in the total new EV. To get to the right answer, update the WACC calculation in the DCF model: replace the risk-free rate with the 5-year Treasury rate as of Dec 15, 2025, and use 4.33% as the total equity risk premium for the United States of America. Then, apply the following changes for the forecast years 2025E-2029E: reduce the operating margin by 2 percentage points in each forecast year, set the yearly revenue growth rate to 1.22% in each forecast year, and set CAPEX equal to D&A in each forecast year. Keep everything else the same. When you reply, round the values to two decimal places, express in $millions.

Please calculate the implied premium / discount of the offer price as proposed to the client relative to the following KVUE share prices, using the values up to 12/08/2025: - Closing price on the final day - 52 week high closing price - 52 week low closing price - last 30 trading day VWAP - last 90 trading day VWAP Report percentages to one decimal place. Use unadjusted prices and calculate VWAP based on the daily closing prices. All dates are in MM/DD/YYYY format. Reply back with your answer here.

Reply back to me with the P/E ratio for KVUE, rounded to two decimal points. Use the implied share price in the DCF model and diluted EPS from the annual financials dated 12/23/2025.

From the figures in merger model, please recalculate the stock portion of the offering price (exchange ratio with 5 decimals) using Kimberly-Clark unadjusted closing share price at 31 Oct 25, and then derive the deal implied Kenvue market price per share at 16 Dec 25. What are the dollar spreads of Kenvue's unadjusted closing price (16 Dec 25) relative to this implied price? Print your final answer to me here. Give it to me as dollars and cents.

Calculate the unlevered beta for Haleon (HLN) using Total Debt and Market Capitalization as of the end of FY2024. Assume 0.227 levered beta for HLN and a 21% Tax rate. Using the unlevered beta for HLN computed above, and the debt and equity values in the model, re-leverage the Beta for Kenvue and update the WACC with the new Re-levered Beta. Reply back with a message, giving the following results: - the New WACC - the New Implied Share Price. - the Variance in $ for Share Price (New-Original) Round all outputs to two decimal places.

Update the DCF model to tell us the following: - Assume operating margin % from 2025E-2029E is updated to KVUE's 2019 operating margin plus 50 basis points - Add 25 basis points to terminal growth rate I want to know the implied share price, rounded to two decimal places. Can you tell me here?

Update the DCF model with the following changes - tax rate for the entire projection period (2025E-2029E) and the WACC build is now the implied tax rate from the second quarter of 2023, calculated as income tax expense over revenue, plus 10% - update beta to 1 - assume revenue growth rate in the projection period matches that of 2024A plus 75 basis points. - update terminal growth rate to be equal to the updated monthly revenue growth rate plus 50 basis points - assume final gross debt is increased by 50% and cash balance is now 10% of the absolute increased gross debt number What is equity value in millions rounded to the nearest whole number? Print your answer back to me as a short message.

In a hypothetical acquisition of Kenvue by Kimberly Clark (merger), at what Kimberly Clark share price would accretion for Pro Forma 2025 EPS for the combined company (Kenvue and Kimberly Clark) would be exactly 0.00%? Assume KVUE' share price before applying a premium is the average closing daily price between 1/1/2025 and 06/30/2025. All other assumptions in the base merger model should not be changed. Return your result as a message, give it in dollars with 2 decimal places.

Take the average close price for KVUE for the week of 12/15/2025 to 12/19/2025, apply a 10% premium, and input that figure in the DCF model. Re-calculate both the 1) cost of equity and 2) after-tax cost of debt. Output your answer as a reply here, rounded to two decimal points.

Replace the risk-free rate in the DCF model with the average of the 10 year and 20 year treasury rates as of 12/22/2025, and assume that the cost of debt is this average value plus 150 basis points. Finally, assume that the tax rate is revised up by 50 basis points for the projection period. What is the absolute difference in terminal value in the original calculation and this updated one? Output your result as a reply here, with millions rounded to two decimal places.

Please get the most recent financial year’s EV/FCF multiples (cutoff date 20 Dec 2025) for the public comparables, as per the slides deck, to calculate a cleaned average using the Modified z-score (Median + MAD) approach, with cutoff = 3.0 for outliers (use the standard scaling constant). Then, use this average as exit multiple to calculate terminal value (TV) and baseline EV for Kenvue. What is the implied share price and the difference relative to the initial implied share price as per the DCF model? For final answers, round TV and EV in nearest million, share price and multiples to two decimal places. Carry full precision for intermediate calculations. Print your answer to me here.

Update KVUE's share price to the closing price as of 1/5/26 and 2029E revenue growth rate to that of 2025E. What is discounted free cash flow in 2029E, including terminal value, rounded to the nearest whole number in millions? I want you to reply with your findings in here. To get the right answer, in the WACC build, assume that KVUE is able to refinance its outstanding debt to the following interest rates: - anything 2030 and shorter is the 5 year treasury rate as of 1/5/26 plus 50 basis points - anything 2033 and longer is the 10 year treasury rate as of 1/5/26 plus 50 basis points

Please run an upside DCF scenario for Kenvue assuming slightly better revenue growth and margins changing the following metrics: 1. Revise 2025E revenue growth rate to 2% stepping up by 0.1% per year until 2029E. 2. Increase existing 2025E – 2029E operating margins by 0.1%. 3. Increase D&A as a % of Net Sales by 0.1% in 2025E, and hold the resulting value flat for 2026E–2029E 4. Increase Operating Current Assets as % of Net Sales in 2025E to 2024A + 0.1% stepping up by 0.1% per year until 2029E. 5. Increase Operating Current Liabilities as % of Net Sales in 2025E to 2024A +0.1% stepping up by 0.1% per year until 2029E. Revise the following financial metrics: 6. Update the WACC calculation in the DCF model by using the 10-year Treasury rate as of Dec 12, 2025 7. Reduce the cost of debt by 0.1%. 8. Add 0.1% to the terminal growth rate. Output the following 1. The revised WACC incorporating the above changes. 2. Difference in the sum of unlevered free cash flow from 2025E – 2029E between the model with the above changes and the original model 3. Difference in terminal value between the model with the above changes and the original model 4. Difference in enterprise value between the model with the above changes and the original model 5. % change in enterprise value between the model with the above changes and the original model 6. Revised implied share price in the model with the above changes 7. % change in revised implied share price between the model with the above changes and the original model Round the implied share price and % values to 2 decimal places and all other values to 0 decimal places. Reply to me with your answer here.

Reply back to me an updated IRR and MOIC. Round final numbers to two decimal places. Use the LBO and comps models to complete the analysis. Follow these assumptions: 1. Remove any comps with Enterprise Value/EBITDA multiples that are negative or greater than 4 times the current median. 2. Calculate the new median EV/EBITDA multiple and use that value +10.00x to replace the exit multiple on the 'LBO' tab of the LBO model 3. Update the senior debt amount on the 'LBO' tab to the minimum EV/Revenue multiple on the comps document

Return the Year 1 - Year 5 CAGR for Adjusted EBITDA. Round to two decimal places and display percentages with %. Write your answer straight back. I want you to use this info to update values in the LBO model: 1. Year 2 revenue growth rate increases 50 bps vs original case 2. Cost of revenue for 'subscription' increases by 15% YoY from Year 4 to Year 5

Make adjustments to the Year 5 growth rate to reach the following Year 1 - Year 5 CAGR for Total Revenue: 22%. Use the LBO model to complete the analysis, but just reply right here. Round value to one decimal place. Make these changes: 1. Year 1 revenue growth rate increases by 188 bps 2. Year 5 revenue growth rate increase by 1/8 the current % premium

Please use the LBO model to calculate the sponsor equity value and IRR for Year 5. Then report the sponsor equity value in US dollars, rounded to the nearest million (e.g., $1,000). Also, report the IRR as a percentage rounded to one decimal place. Send me your reply here. Follow these steps: - Increase the Senior Debt leverage to 6.0x from 5.0x. - Decrease the Senior Debt interest rate to 6.0% from 7.5%. - Reflect mandatory annual amortization of the Senior Debt, calculated as 2.0% of the opening principal balance of 2,088.3. - Increase the Subordinated Debt leverage to 2.0x from 1.5x. - Decrease the Subordinated Debt interest rate to 8.0% from 10.0%.

Please assess the impact of reducing the entry premium by 5% and illustrate the potential impact on the deal return. Use the LBO model. 1. Reduce the deal premium by 5%, from 35% to 30%. 2. Reduce the Exit Multiple from 35.0x to 34.0x. 3. Ensure all interest expense calculations are based on the average of the beginning and ending debt balance in the period. Report just the MOIC and IRR %, return it back here. All percentages and multiples must be rounded to two decimal places.

Please create a new scenario within the LBO model to assess the impact on Elastic’s Net Profit, assuming that for all years over the projection period (Year 1 to Year 5), Research and Development expenses margins are 10% higher and General and Administrative expenses margins are 2% higher. In the existing file, add a new tab and show values for "Net Profit" and "Net Profit Margin", across Year 1, Year 3, and Year 5. All monetary results must be displayed in USD millions, rounded to two decimal places, and all percentages must also be rounded to two decimal points.

Benchmark the results for Elastic NV Q2'FY26 (ending 10/31/2025) against their industry peers as reported in Public Comparables (for Q2). 1. Calculate the public comparables mean (average) for Market Cap, Enterprise Value, Enterprise Value/Revenue, and Enterprise Value/EBITDA 2. State the percent by which Elastic N.V. Underperformed or Overperformed its peers average across each valuation metric Constraints you MUST follow: 1. Express all multiples to two decimal places, and include 'x' after the second decimal 2. Express Market Cap and Enterprise Value as whole numbers 3. To manage large and extreme values, apply the following for the Public Comparables: 3a. Exclude Market Cap > $1 trillion in calculating the Market Cap average 3b. Exclude Enterprise Value > $1 trillion in calculating the Enterprise Value average 3c. Exclude Negative Multiples for Enterprise Value/Revenue and Enterprise Value/EBITDA 3d. Exclude Multiples > 200.00x for Enterprise Value/EBITDA Write your reply to me here with everything that I asked for.

Assess if the sponsor can still meet the 20% IRR target at the Year 5 exit, given higher cost of revenues. 1. Increase subscription cost as % of subscription revenues by 1 percentage point in Year 1, then keep it constant in the remaining projection years. 2. Increase services cost as % of services revenues by 1 percentage point in Year 1, then keep it constant in the remaining projection years. Add a new worksheet to the Elastic NV LBO model. It must show Net Debt at Exit, Sponsor Equity Value at Exit, IRR %. All monetary results to be displayed in USD millions, rounded to two decimal places, and all percentages must be rounded to two decimal points.

Assess how much certain business drivers must move to bring IRR below 20%. The stock price has fallen to $87.00. Use the LBO model for the info. 1. Find the critical point (percentages to 2 decimal places) for each of the below business drivers at which rounded IRR would be pushed down to 19.99% from above: a) 'Growth rate scale' (correct the approach for Year 1/2) b) 'Customer acquisition costs' c) 'R&D cost' d) 'Debt costs' e) 'EBITDA multiple' Assumptions and constraints: 1. EBITDA is not to fall below $91 million for any year. If this threshold is passed the new constraint becomes EBITDA for each individual year instead of the IRR. 2. 'Debt costs' should be set to 0% for all other sensitivities. Create a new sheet that shows values for the five major business drivers.

Please create a new scenario within the LBO model to assess if the sponsor can still meet the 20% IRR target at the Year 5 exit, given higher Net Working Capital needs. 1. Increase accounts receivable as % of sale by 2 percentage points value in Year 1, then keep it constant in the remaining projection years 2. Increase prepaid expenses and other current assets as % of sale by 2 percentage points in Year 1, then keep it constant in the remaining projection years. Output: Add a new worksheet to the LBO model titled “NWC Scenario”. Add the Net Debt at Exit, Sponsor Equity Value at Exit, IRR %. All monetary results must be displayed in USD millions, rounded to two decimal places, and all percentages must also be rounded to two decimal points.

Print out here the updated IRR and MOIC, rounded to two decimal places. Use the precedent transactions document and LBO model to complete the analysis. Assumptions: 1. Adjust the LBO model to have the premium % equal to Splunk Inc's revenue growth rate in the precedent transactions document 2. Adjust year 4 revenue growth in the LBO to New Relic, Inc's revenue growth rate in the precedent transactions document

I want you to tell me for Year 1 - Year 5: (1) Total revenue CAGR(2) Subscription Cost of Revenue CAGR (3) Sales and Marketing Expenses CAGR (4) EBITDA CAGR But first adjust revenue growth rate to be 7.5% in year 1, 50 bps YoY increase to year 2, 150 bps YoY increase to year 3, 100 bps increase vs original case in year 4, and original case for year 5. Reply here, with 2 decimal points.

Run a single downside scenario where all modeled sensitivity factors receive a 20% shock, in the direction that would adversely impact IRR. What would the new IRR & Sponsor Equity Value be? Use the LBO model to answer. In the operating assumptions, update the sensitivity shocks of the major business drivers, including: a) -20% 'Growth rate scale', total revenue growth for Elastic for years 1-5 b) 20% 'Customer acquisition costs', total sales and marketing costs for years 1-5 for Elastic c) 20% 'R&D cost', the costs for research and development that Elastic is expected to pay from year 1 to 5 in the future d) 20% 'Debt costs', the interest costs that Elastic would have to pay e) -20% 'EBITDA multiple', the exit multiple that is used in determining the exit valuation Output, in a NEW tab in the existing LBO model, values for “IRR (All factors shocked by 20%)” and “Sponsor Equity Value (All factors shocked by 20%)”. Round all values to two decimal places, and display monetary values in millions ($m). I also want you to give an assessment of whether further analysis is required, based on whether the downside loses money.

Please evaluate the impact on Elastic's IRR% at exit, assuming a slowdown in Total Revenues growth. Return the following here: Year 5 Adj. EBITDA, EV value at Exit, Net Debt at Exit, Sponsor Equity Value at Exit, Sponsor Equity Value at Entry, MOIC, and IRR %. use the LBO model. Respond with your answers straight back here. Use this for your work: 1. Decrease the existing Total Revenues growth rate in Year 3 by 5% of its original value in the base case (a 5% relative decrease). 2. Decrease the existing Total Revenues growth rate in Year 4 by 10% of its original value in the base case (a 10% relative decrease). 3. Decrease the existing Total Revenues growth rate in Year 5 by 15% of its original value in the base case (a 15% relative decrease). All monetary results must be displayed in USD millions, rounded to 2 decimal places, and all percentages must also be rounded to 2 decimal points.

Use the LBO model to assess the impact of a lower interest rate environment on the Year 5 exit IRR% target. 1. Decrease the existing senior debt cost by 50 bps starting at the beginning of Year 2. The senior debt cost should remain constant thereafter. 2. Decrease the existing subordinated debt cost by 25 bps starting at the beginning of Year 3. The subordinated debt cost should remain constant thereafter. 3. Recalculate the total interest cost for the impacted projection period (Year 2 to Year 5). 4. Note that all interest expense calculations must be based on the average of the beginning and ending debt balance in the period. Tell me the Net Debt at Exit, Sponsor Equity Value at Exit, MOIC, and IRR %. Print it here. All monetary results must be displayed in USD millions, rounded to two decimal places, and all percentages and multiples must also be rounded to two decimal points.

Using the assumptions below, calculate the sponsor equity value and IRR for Year 5. Then, report the sponsor equity value in US dollars, rounded to the nearest million (e.g., $1,000). Report the IRR as a percentage rounded to one decimal place. Print your answer here. Use the LBO model with the following specifications: - Increase the Subordinated Debt leverage to 2.0x from 1.5x. - Implement mandatory annual amortization of the Subordinated Debt, calculated as 1.5% of the opening principal balance of 696.1. - For each of Years 1 through 5, calculate mandatory annual amortization on Subordinated Debt as 1.5% of the opening principal balance. - Subtract both the mandatory annual amortization and any additional paydown from the beginning Subordinated Debt balance to arrive at the ending Subordinated Debt balance for that year. - Repeat this sequence each year so that the Subordinated Debt schedule reflects both annual amortization and any paydowns across Years 1 through 5. - To determine the ending Senior Debt balance from Year 1 through Year 5, incorporate the following: - Discretionary Repayment (excess cash sweep) is calculated as 50.0% of the Available Cash for Debt Repayment. - Compute discretionary repayment as 50.0% of Available Cash for Debt Repayment and deduct this amount from the beginning balance of Senior Debt to arrive at the ending balance. - This sequence is repeated each year so the debt schedule reflects discretionary paydowns tied to Available Cash for Debt Repayment. - Each year, Total Debt Paydown should equal the sum of all Senior Debt paydowns plus both the mandatory and any additional repayments on Subordinated Debt.

Use the LBO model. I want some new analyses: - Decrease the “Premium” from 35.0% to 25.0% on the "LBO" tab - Decrease the “Adj. EBITDA Multiple” from 40.0x to 25.0x on the "LBO" tab - Update revenue growth constant at 15.0% per year from Year 2 through Year 5. Write out to me here: 1. Sponsor Equity Value in Year 5. 2. IRR in Year 5. Round it to the nearest million (e.g., $1,000). Report the IRR as % rounded to one decimal place.

Use Planet Fitness' latest financial model that Advent updated based on their specifications and assess Advent’s “ability to pay” to reach 25% IRR after 5 years if there are net revenue synergies between Planet Fitness and a portfolio company that Advent already holds. Assume exit multiple is 18x and estimated revenue synergies are as follows: $10 million per quarter (Q1-Q4 2026); $50 million per quarter (Q1-Q4 2027 and beyond). Assume no incremental costs associated with the net revenue synergies. Reply to me with a message outlining the implied premium paid to reach 25% IRR, assuming the revenue synergies above.

Use Planet Fitness' latest financial model, in the"Copy of LBO" tab, and sensitize $ operating expenditure each year by +/- 5% against the base case for each year from 2026 through 2030; calculate the resultant change in FY30 IRR relative to the base case. (For illustration, if opex in FY26 was $1,000, the downside (+5% opex) case would be $1,050 opex and the upside case (- 5% opex) would be $950 opex.) Create a new Sheet and make a table with: - Rows: "Upside", "Base", "Downside" scenarios - Columns: "Scenario"; "IRR"; "Accretion/Dilution" Where "IRR" is the IRR for the given scenario and "Accretion/Dilution" is the difference in the scenario IRR against the base case in absolute % terms. Format all percentages to 2% decimal places

Update the LBO analysis tab "Copy of LBO". It needs to include a single potential add on acquisition in FY2027E. Assess the impacts on the 5-year LBO analysis. Use SOFR actual data. Add to that tab, the total debt, total enterprise value, and sponsor IRR. Round $ to millions and others to 1 decimal point. General assumptions: -Target EBITDA at time of acquisition is $41mm -Assume target EBITDA grows at the same CAGR as Planet Fitness standalone EBITDA forecast from 27-30 -Acquisition EBITDA multiple of 10.0x -No synergies -Acquisition funded first by all available cash on hand (less minimum cash), then by a revolver. Revolver assumptions: *The revolver was left undrawn at purchase *Priced at SOFR + 400 (for the purpose of this analysis, pricing will be fixed throughout the forecast at the 30-day Average SOFR as of 11/21 in attached file titled "SOFR (Actual).xlsx") *Maximum revolver capacity of $1,000mm *Unused revolver commitment fee of 0.25% *Revolver paydown is prioritized before cash sweep to any other debt

Output the year 5 Equity Value to Sponsors and IRR (with a 5 year exit). From the existing LBO model, update values to both a 20% equity rollover from existing shareholders and a 10% management option pool. Write the information straight here. Assumptions: -Existing shareholders have agreed to roll 20% of their exit proceeds into the deal as a source of funds (i.e., note that existing shareholders will have a 20% pro forma equity stake) -Impact of net option dilution calculation as follows: *Options only trigger if exit equity is greater than entry equity *If options trigger, gross proceeds to management is total exit equity multiplied by the percentage of management's option pool *Netted against management's cost to exercise, calculated as the value of entry equity multiplied by percentage of management's option pool Round monetary values to nearest whole number. Round all other values to 1 decimal point.

Please calculate the DCF value per share applying the midyear convention. Keep all other assumptions the same in the existing model. Provide your answer right here, rounded to the nearest cent

Using the LBO model, what would the revenue growth % in 2025E have to be to yield an IRR of 20.0% in 2029E? Round to 2 decimal places. Reply to me in here please.

Using the DCF calculate the implied levered FCF yield for CNS in 2030E for (1) the perpetuity growth method and (2) the exit multiple method. Assume a 10% WACC, 2% terminal growth rate, and an 11x exit multiple. Provide values to one decimal place. Write out your reply to me here.

From the LBO, assume a 15% premium is offered to CNS holders and max transaction leverage of Term loan B is $1,040. What is the revised IRR and MoM for 2029E, rounded to one decimal place? Reply here.

Provide the mean implied equity value for CNS from the Comparables and Precedents using 2025E EBITDA, as well as the implied equity value from the DCF and LBO using the base DCF and assumed offer price. Provide the results of all four methods and the mean in $ million, to one decimal place. Give it as a message right here.

Your task is to evaluate the impact of financing constraints on Project Vanguard's take-private economics and develop a revised LBO case reflecting a capped leverage scenario using the LBO model. • Term Loan B (TLB): cap maximum proceeds at $1,250 MM • Adjust Sponsor Equity so that Total Sources = Total Uses, maintaining a constant enterprise value (EV) at entry (excluding fees and cash to balance sheet). • Exit Multiple: assume 2030E Exit Multiple of 18.5x In the existing LBO model, I want you to compute the Implied Adj. EBITDA Entry Multiple (2024A). Label this calculation as: “Implied Adj. EBITDA Entry Multiple (2024A)”. Also, create a 2x2 sensitivity tables for Sponsor IRR (%). Set rows as: Premium to Current (15.0%, 25.0%) and columns as: Exit Multiple (17.5x, 18.5x). Populate the tables with recalculated IRR values based on the revised capital structure reflecting the Term Loan B cap. Round the final results to one decimal place and keep the same formatting as the original sensitivity table.

Assume that CNS has been taken private as of the start of FY25E. The new PE owners have decided to reduce employee compensation by 50% of the value of stock-based compensation in the previous LBO forecast (when CNS was a public company). Based on this, calculate the revised DCF per share valuation of CNS. Keep all assumptions the same per the DCF base case. Provide your response right here, rounded to the nearest cent.

Using the precedents and DCF analysis calculate an implied share price for CNS to 2 decimal places. Exclude transactions where the target had <$90 B in AUM. Using the forward EBITDA from the DCF, assume a 10% increase in total expenses and only a 5% increase in Depreciation and amortization. Edit the existing sheet to provide the share price build (EV / EBITDA, 2025E EBITDA, Implied EV, Net Debt, Implied Market Cap, FDSO and share price), starting in the 'Precedents' tab. Round all values to 2 decimal places.

Can we see what the DCF per share value is if the terminal value is based on EV / AUM of the peer set? Let's exclude AMG and JHG for purposes of this exercise. Assume that AUM grows linearly with management fees, round to the nearest cent. Print your answer back here.

What is the EV and implied share price of CNS in the DCF model using both Gordon growth model and exit multiple approach if each business segment grows as outlined below over the projection period of 2025 to 2030? Segment 1 - Investment advisory and administration fees grows at 7.0% revenue growth per annum Segment 2 - Distribution and service fees grows at 6.0% revenue growth per annum Segment 3 - Other grows at 5.0% revenue growth per annum Output the following to me with a short message in reply: 1. EV using the Gordon growth method 2. Implied share price using the Gordon growth method 3. EV using the exit multiple approach 4. Implied share price using the exit multiple approach Report share price in $ and to 2 decimal places, report EV in whole number and in millions. For operating expenses and capex use the Operating Assumptions (provided as a % of total revenue) laid out in the “LBO Model-hardcoded” tab.

Using a discounted cash flow (DCF) model, what is the implied share price under the following assumptions: - Revenue growth is 2.0 percentage points lower than the current growth rates in each year from 2025 to 2030. - Employee compensation and benefits as a percentage of revenue are 2.0 percentage points higher than the current figures in each year from 2025 to 2030. - Mid-year convention is used. I want you to (1) Tell me the implied share price using the Gordon Growth Method. Then, (2) tell me the implied share price using the Exit Multiple Approach. Reply to me with a message outlining these values in USD, rounded to two decimal places.

Using the LBO model calculate FY2025 interest expense and the corresponding FY2025 Adj. EBITDA / Interest Coverage ratio based on the capital structure sized at 4.5x entry gross leverage (Gross Debt / FY2024 Adj. EBITDA). Assume the transaction closes in FY2024 and the sponsor holds the asset through the 2030E exit. Round the dollar values to whole numbers and multiples to one decimal point. Respond here with a short message.

Management believes that the appropriate valuation of the DCF terminal value is the EV / mgmt. fees portfolio multiple of the asset managers peer set per the comparables analysis excluding JHG and AMG. Calculate CNS's implied terminal growth rate using that approach. Keep all other assumptions the same per the DCF base case. Provide your findings as a message here, rounding percentage values to 2 decimal places.

Output two values for me: 1. The implied share price using the Gordon growth method 2. The implied share price using the exit multiple approach You will need to update the DCF model with the following changes to get the right answer: 1. Change depreciation and amortization as a percentage of total revenue from 2025 to 2030 to the same rate as 2024 2. Change Total current assets as a percentage of total revenue from 2025 to 2030 to the same rate as 2024 3. Change Total current liabilities as a percentage of total revenue from 2025 to 2030 to the same rate as 2024 4. Change revenue growth from 2025 to 2030 to the same rate as revenue growth between 2023 and 2024 5. Change distribution and service fee to 15% of the total revenue from 2025 to 2030 Respond with a short message here. Report share price in $ and round it to 2 decimal places

The Private Equity Sponsor wants to extract cash via a "Dividend Recapitalization" at the end of 2027. Using the MFC model, you must size the Maximum Special Dividend the company can pay while remaining compliant with a strict Debt Service Coverage Ratio (DSCR) covenant. Report the 2027 CFADS, Max Total Debt, and the Net Special Dividend ($000s). Reply back here with the numbers. Scenarios: 1. Timing: The dividend recap transaction closes at the end of Fiscal Year 2027. Use 2027 forecast data. 2. Covenant Constraint: - Pro Forma DSCR, defined as CFADS / debt service, must be at least 1.40x. - Cash Taxes (Override): Calculate normalized cash taxes as 25.0% for the purpose of dividend recap 3. New Debt Structure: - The company will refinance all existing debt into a new Senior Facility. - Interest Rate: 6.5% (Fixed). - Mandatory Amortization: 1.0% of Principal per year. - Total Service Constant: 7.5% (Interest + Amort). 4. Dividend Recap Transaction Fees: 2.0% of the Incremental Debt Raised (New Total Debt - Old Existing Debt). Instructions: 1. Calculate 2027 CFADS using the override tax assumption. 2. Solve for the Maximum Total Debt Capacity allowed by the 1.40x DSCR constraint. 3. Calculate the Incremental Debt (Max Total Debt - Existing 2027 Year-End Debt). 4. Deduct dividend recap transaction fees to find the Net Special Dividend.

Using KSchool's DCF, update the 2026 revenue growth rate so that the 2024-2028 Revenue CAGR is equal to INST's 2019-2023 selling and marketing expense CAGR. Then make it a 6-year projection period and keep assumptions for the 6th year the same from 2028. Add 25bps to Terminal Growth Rate. Accounting for these changes, return the implied share price to me right in here. Round the numbers to two decimal places.

Use the LBO model with the following indicative debt package to calculate these values --> then, return them back to me here 1/ Equity contribution 2/ Central case IRR 3/ Central case MOIC 4/ Exit net debt 5/ Maximum amount of revolver drawn Term Loan A: Amount: $1.8bn Term: 7 years, straight line amortising Rate: 7-year US Treasury (market rate) + 225bps Arrangement Fee: 0.75% Term Loan B: Amount: $600m Term: 10 years, bullet repayment Rate: 10-year US Treasury (market rate) + 275bps Arrangement Fee: 0.75% Revolver: Amount: $600m Rate: 5.5% Round percentages and multiples to two decimal places, and dollar amounts in millions, rounded to the nearest whole number. Assume market rates from 28-Nov-2025 (U.S. Treasury Daily CMT).

Calculate the 2027P equity value implied by the LBO output. Replace the 2027P exit EBITDA multiple with the average calculated FY2023 EV/EBITDA multiple for CHGG and LOPE. Present the result to me here, rounded to the nearest $ million

Can you help me calculate a new implied share price, rounded to two decimal places? Return your answer to me here Update the DCF so that its 2024-2028 R&D CAGR is equal to PWSC's 2019-2023 R&D CAGR. Update revenue growth rate for 2027 to achieve this. Then adjust operating expenses (excluding R&D) in year 2028 so that its 2024-2028 CAGR is one half PWSC's 2019-2023 G&A CAGR. Lastly, update the DCF with the average 10-year treasury rate for 12/2/2025 - 12/19/2025.

Referencing the KSchool DCF, how much does the company need to increase or decrease 2023's earnings to have it's P/E ratio in 2023 equal to the sector average for communication services as of 1/1/2026. Assume P/E is calculated using its implied share price from the DCF model. Return a short reply with the dollar amount in millions, rounded to nearest integer.

Calculate the 2028P equity value implied by the LBO output, assuming an exit multiple of 32.0x. Present your result to me as a message in here, rounded to the nearest $ million. Use the following conditions: - Set maximum leverage on the Term Loan A, measured against 2023A EBITDA, at 10.0x, with any remaining funding requirement to be satisfied through an increased equity contribution. - For revenue growth, calculate the average 2024 year‑over‑year revenue growth rate of the following three companies—Duolingo, Inc. (NASDAQ: DUOL), Coursera, Inc. (NYSE: COUR), and Grand Canyon Education, Inc (NASDAQ: LOPE). Apply this single average 2024 growth rate to the company’s revenue in 2024, and assume this constant revenue growth rate from 2025P - 2028P. - All other assumptions remain unchanged.

Using the DCF model, update the equity risk premium to be the risk-free rate plus 150 basis points and the cost of debt to be the risk-free rate plus 300 basis points Output the following rounded to two decimal places: - Implied DCF share price with a terminal growth rate of 1.25% and 5-year risk free rate of 12/12/2025 - Implied DCF share price with a terminal growth rate of 1.25% and 7-year risk free rate of 12/12/2025 - Implied DCF share price with a terminal growth rate of 1.75% and 5-year risk free rate of 12/12/2025 - Implied DCF share price with a terminal growth rate of 1.75% and 7-year risk free rate of 12/12/2025

I want to know the implied DCF share price with a revised scenario, rounded to two decimal points. Do your calculate by updating the cost of debt in the DCF model to be the average between the 1 year and the 5 year treasury rates as of 12/22/2025 plus 100 basis points. Set revenue growth rate to 12% for the entirety of the projection period and update the equity beta to 1.3. Don't edit any files, just print your answer back here.

Calculate the updated PV of FCF. Output it here. Round it to the nearest whole number, with zero decimals. Print your answer as a reply back here. Account for: 1. Identify the competitor in the comparable analysis file with the lowest EV/Revenue multiple. 2. Replace KSchool's gross margin rate for the projection periods with the FY 2024 gross margin of the competitor identified above and add +10%. 3. Replace KSchool's Operating expenses rate for the projection periods as the average of SG&A expenses as a percentage of revenue of the competitor from FY 2021 to FY 2024. 4. Update the risk-free rate to be the 20 year treasury yield from Oct 20, 2025.

Use the valuation model, updating the 'Per Share' and 'Premium' values for the low, mid, and high cases to reflect Blackstone’s acquisition of Company X and the assumptions below. Reply back to me with the per share data in € and the Premium. Round percentages to 1 decimal place. Assumptions to follow - Blackstone acquired Company X in 2020 at an EV of €1000M - Company X revenue was €100M - Company X EBITDA was €50M - Blackstone acquired Company X at a 45% premium - The Stevanato - SVM Automatik transaction is an outlier and should be excluded from the analysis - The Mid EV/EBITDA multiple is the average of the High and Low multiples - Gerresheimer recently completed a capital raise that is not reflected in the base case, issuing10 million shares at €30.00 per share - Gerresheimer used €200M of the proceeds raised to acquire 49% of Company Y that has €50M in EBITDA

Assume that 10% of Aptar's Asian pharma revenue will shift entirely into European pharma revenue. Retroactively apply this to 2024 financials. Refer to the 2024 ATR report. Return a short message with the values for Asia Pharma and Europe Pharma for their corresponding revenue under this set of assumptions. Round dollar amounts to the nearest thousand.

From Becton Dickinson's FY2025 Annual Report assume the FDA finds that one violation regarding the Alaris SE infusion pumps, and decides the company is in violation, and enforces the consent decree on Alaris SE infusion pumps from November 29, 2024, to November 28, 2025, inclusive. Compute the average dollar burden of the penalty on BDX average shareholder. Output the result in USD as a reply to me here, rounded to 4 decimal places. Assume a 30-day month and a 360-day year.

Please access the 2024 Huhtamaki Annual Report and calculate the Net Sales per employee at end of period for 2023 and 2024. Reply to me here with the the Euros per Employee, rounded to the nearest full Euro amount.

The current standalone DCF valuation does not include synergies. In the valuation model, re-run the analysis to include synergies, integration, and transaction costs. In the accretion dilution model project, the "Synergies" and "ProForma_Combined" tabs contain these assumptions. 1. Update the vauation model "Project_Rheingold_Valuation_Model(final)" 2. Implement One-Time Integration Costs (After-Tax), Transaction Costs (After-Tax), and EBITDA Synergy (pre-tax) into the DCF analysis, maintaining all existing DCF assumptions. 3. Report back for me: "Sum of PV of FCF (2026-2030)", "PV of Terminal Value", "Enterprise Value", "Implied EV/EBITDA(2025E)", "Implied EV/Revenue(2025E)". 4. Round all final monetary values (millions) and multiples to one decimal place.

Using the 2024 ATR annual report, analyze the results of a 15% tariff on Aptar Group’s FY2024 net income. Assume the 15% applies only to Cost of Sales, exclusive of depreciation and amortization. Round all values to the nearest thousand. Use a 20.35% tax rate. Output just the pro-forma net income as a reply here.

In The Aptar Group's 2024 annual report, extract global revenue for the Pharma segment in 2023 and 2024. Compute the aggregate dollar change in thousands of USD adjusted for 7.1% 2024 global inflation and express the result in USD, rounded to the nearest thousand. Print back to me what you find please.

You have access to the accretion dilution model. Create a new sheet and tell me the Proforma Interest Coverage for 2027 and 2028. In doing so, assume: - Aptar's Interest expense as a percentage of sales in sheet "Aptar_Historicals" is now 2% for the projection period (2025E - 2030E) - Aptar's Total OPEX as a percentage of sales in sheet "Aptar_Historicals" is now 25% for the projection period (2025E - 2030E) - Aptar's Tax Rate as a percentage of sales in sheet "Aptar_Historicals" is now 35% for the projection period (2025E - 2030E) - Interest on Existing debt remains unchanged. - Cost synergies target in sheet "Synergies" is 35% - Synergies in sheet "Synergies" will be 50% realized in 2025, 2026 and 2027 and 100% in 2028 and after - Cost to achieve synergies in sheet "Synergies" will be 0% Perform the calculations in Euros in thousands and round to one decimal place.

Calculate the incremental Enterprise Value the Gerresheimer acquisition will add to the Aptar Group. Only reference the board presentation. Assume multiples for The Aptar Group remain constant and reference the acquisition multiple of 4.5x for Gerresheimer to arrive at the acquisition price. Use 2025E EBITDA. Do not incorporate synergies. Express your answer as a message right here. Give numbers in USD million, rounded to one decimal point.

Determine the effective interest rate of The Aptar Group acquiring Gerresheimer at a 35% premium. Then compare that effective interest rate to the effective interest rate of The Aptar Group as a standalone without acquisition. Use the board presentation to calculate the effective interest rates. Round the interest rates to one decimal point. Assume a 25% corporate tax rate. Create a New Sheet file with the Effective Interest Rate for Aptar Standalone and Aptar with Acquisition.

ATR is expecting to write down the goodwill related to Pharma to zero following the merger with GXI. Referring to the 2024 ATR 10K calculate the new total ending Goodwill under this write down scenario and output the number. Round it to the nearest thousand dollars. Tell me the information that I want in here.

Create a new Spreadsheet for me. Please compute a new Adjusted EBITDA value for the following companies: West Pharmaceutical, Stevanato Group, Schlott Pharma, Berry Global, Aptar Group using the board presentation, by taking the peer group median EBITDA margin and the corresponding revenue values. Multiply the Adjusted EBITDA values by the peer group median EBITDA multiple to derive a new Enterprise Value for each company. Report back the values. Display all margins and multiples to one decimal place and revenues, Adjusted EBITDA, and EVs to the nearest whole number, expressed in $mm.

Calculate the 2030E discounted EV/Revenue multiples for West Pharmaceutical, Stevanato Group, Schott Pharma, and Aptar Group. Reference the valuation model on the "Trading Comps" tab. Note that the financial and valuation metrics reflect 2025E assumptions. For each company, assume that the long-term revenue growth rate starting in 2026E is equal to its FY23 - FY24 YOY net sales growth rate, and the discount rates are as follows: West Pharmaceutical -> Reference WST 2024 10K for revenue growth -> Discount Rate: 9.4% Stevanato Group -> Reference Stevanto 2024 20-F for revenue growth -> Discount Rate: 8.8% Schott Pharma -> Reference Schott 2024 annual report for revenue growth -> Discount Rate: 10.0% Aptar Group -> Reference ATR 2024 10K for revenue growth -> Discount Rate: 7.4% Round the final output to one decimal and express it as a multiple. Print out what you find for me in here.

Using the accretion dilution model, produce the deliverables outlined below. Round all the figures to whole numbers, present monetary amounts in $ mm and display percentages to two decimals places. The client wants to make the following adjustments to the DCF model. - Revise the COGS assumptions for both Cost of Product & Cost of software and rentals as a % of Revenue, and make it a three-year moving average for 2025E and future years. For years 2026E, 2027E, 2028E and 2029E, add 25 basis points to each year's three-year moving average. Update the gross profit based on these assumptions - Revise the Selling, general and administrative expenses by making it a three-year moving average for 2025E and future years - Revise the Research and development expenses to 10% of sales for years 2026E through 2029E if prior years discounted cashflows exceed $1,000 mm and apply a three-year moving average for years where discounted cashflows are below $1,000 mm - Revise the revenue growth assumptions by changing 2025E growth to -0.5% for both Sales of Product & Sales of Software and Rentals. For years 2026E through 2029E, use a three year moving average for each year and subtract 50 basis points from that calculated growth rate each year - Use a WACC calculated by using only Zimmer Biomet and Smith & Nephew in WACC Calculation as comparables - Use a terminal growth rate of 1.5% Return a short message explaining to me: 1. Sum of Discounted Value of cashflows for 2025E through 2029E excluding the terminal value. 2. Terminal Value. 3. Discounted Terminal Value. 4. Enterprise Value 5. Discounted Terminal Value as a percentage of Enterprise Value.

Assume that no transaction happens with SOLV. Now, calculate the impact of a large investment in AI for MMM shareholders as an alternative capital allocation strategy using the accretion dilution model. Print me back the answer right here, showing: Total new debt from MMM's AI related initiatives Total debt Total after tax Interest Expense PF Net Income Pro Forma EPS EPS accretion/dilution Ending cash Using the following assumptions calculate the impact to EPS for MMM shareholders assuming no transaction with SOLV: - Required investment in technology of $5 billion - half of the investment to be financed from cash in hand and the rest with new debt at a 8.5% cost - Reduction in work force resulting cost savings pre tax of $1 billion - Severance cost associated with the reduction in work force of $4 billion to be financed with $500 million of cash in hand and the rest with new debt at a 12% cost. Assume 50% of the total severance costs will be paid upfront and the remainder over a 4 year period in equal amounts with the first payment beginning in year 1. These costs should be accounted as an expense and not capitalized. Any remaining cash from the debt not used upfront goes to the balance sheet - Increase in power costs associated with the investment in AI of $600 million per year - Apply an incremental 10% tax on power cost for every $100 million of power spend as a pollution compensation policy. Assume the 10% tax doubles for every $100 million of incremental spend. Assume this tax is embedded in the cost. - Assume to bolster balance sheet, MMM also issues equity for equivalent of $2 billion dollars at a issuing price of $250 dollars per share Remember in your answer: EPS should have two decimals. Percentages should have two decimals. All other values given as $ in millions, no decimals.

We want to do some historical analysis. Using stock prices for the 250 trading days up to Nov 19, 2025, calculate the beta for SOLVM to the XLV ETF. Then over the same time period, calculate the beta for MMM to the XLI ETF. Using the CAPM, calculate the cost of equity (Ke) for each company. Assume an expected market return of 12% and a risk-free rate of 3.95%. Print the answers back here. Use the accretion dilution model for stock prices for SOLV and MMM. Use the XLV Healthcare ETF and XLI Industrials ETF files for stock prices for the XLV and XLI ETFs. Use adjusted close prices. Present betas as a decimal, rounded to two decimal places. Present the cost of equity as a percentage, rounded to 1 decimal place.

In the Accretion / Dilution Model, use the capital structure and shares outstanding assumptions for Solventum (SOLV) to calculate levered free cash flow and price per share. Specifically, use the following incremental assumptions: - Revenue Growth Rate: 2.0% beginning in FY25E through the end of the forecast period FY29E - SOLV Interest Rate: 5.50% to forecast interest expense - Other expense (income), net: Remains $0.00 in each period - Cost of Equity: Use the average of cost of equity of the three comps used in the WACC calculation (Exclude Zimmer Biomet) - Capex: 110.0% of D&A beginning in FY25E through the end of the forecast period FY29E With all that, calculate the implied price per share to 2 decimal places. Reply straight back to me here.

Estimate impact to EPS of MMM divesting 1/3, 2/3 or 100% of its holdings in SOLV. Using the accretion dilution model, calculate the EPS impact of selling the different amounts of shares. Assume that MMM has to pay a 20% tax on the proceeds from the divestiture of the first 1/3 of the shares, a 25% tax on the next 1/3 and a 30% tax on the last 1/3 of the shares. Assume that net proceeds from the divestiture are invested in an instruments that pays an 8% interest rate upfront and that interest income is taxed at 35%. Tell me: 1- Percentage of SOLV Divested 2- EPS Accretion / Dilution 3- Pro forma net income Pro forma net income should incorporate the impact of investment of net proceeds from divestiture at 8% and after tax. All figures should be presented with two decimals. Output the final results by making a new Spreadsheet file.

Present all $ output values in million, round all output values to 1 decimal place. Get the following directly from the accretion dilution model: - Enterprise Value (DCF output) - PV of Free Cash Flows (2025–2029) - Terminal Free Cash Flow (2029) - Terminal Growth Rate (g) - WACC Assume that 3M ownership stake = 20% and: 1. Compute 3M’s stake value using the current DCF Enterprise Value. 2. Reduce each of the FCFs for 2025–2029 by 10% and recalculate the PV of those 5 cash flows using the 7.6% WACC. 3. Recalculate the Terminal Value using the reduced 2029 FCF but keeping the same 3% terminal growth rate and 7.6% WACC. 4. Combine the new PV(FCFs) and PV(TV) to estimate a downside Enterprise Value, and compute the implied downside stake value for 3M. 5. Calculate the percentage loss based on the implied stake values Present your findings in a new deck with: - 3M's Current Implied Stake Value - Sum of PV of Revised Discounted FCFs - Recalculated Terminal Value discounted to the Present - 3M's Revised Stake Value - Percentage Loss

Using the merger model and 0000066740-25-000089, please calculate: 1. The Number of Shares Repurchased. 2. The Revised Enterprise Value. 3. The Revised EV/EBITDA multiple for 3M. 4. The Revised P/E ratio for 3M. Present all monetary values in million dollars, rounded to nearest million. Round the number of shares, ratios and percentages to two decimal places. Print your reply back here as a short message. Assumptions and guidance for deliverables: - Note that debt to equity ratio for 3M as of end September 2025 can be calculated using 3M Total Equity in the other file. - Assume that 3M Share price dropped by 8% before the buyback and remained flat after that. - Assume that the amount of proceeds from sale of Solventum are used to paydown debt by 3M to bring debt to equity ratio down to 2.60x. - The left over proceeds from sale of Solventum after paying debt is used by 3M to repurchase shares. - Assume that EBITDA can be adjusted to 2025E EBITDA by multiplying it with 1.05 for simplicity. - For the enterprise value working, use the cash in tab "Assumptions S2". - For the Revised P/E ratio, use the TTM net income given in "Assumptions S2" tab.

Calculate the intrinsic value per share of Solventum based on these assumptions. Use the accretion dilution model. - Lower the gross margin % to 52% for the forecast period 2026E through 2029E. - Change Research & Development expenses as % of Sales to 15% wherein the discounted cashflow is higher than $1,100 mm in the preceding year, and to 10% wherein the discounted cashflow is lower than $1,100 mm in the preceding year for the years 2026E through 2029E. - Remove the comparable Koninklijke Philips from the WACC calculation. - Change the terminal growth rate to 2.0%. - Convert fixed CAPEX to a % of sales, and project using the last 3-year moving average to calculate it for the years 2025E through 2029E. - Update the discounting with 1/12 for 2025E, given that we are at the start of Dec 2025. Adjust the future years discounting convention accordingly. - Pull shares outstanding and Net debt from the "Assumptions S1" tab. Round the final deliverable to two decimal places and express in $ terms. Give me your response right here.

Evaluate the sensitivity of EPS impact to synergies and cost of new debt for the acquisition of SOLV by MMM using the accretion dilution model. Create a new tab in the file, with a table to show EPS impact (accretion or dilution). - Show synergies in increments of $300 million (300m, 600m). - Show cost of new debt in increments of 5ppts (15%, 20%). - Show the price premium per share at different synergy levels. - Assume the price premium per share is 25% for no synergies and increases by 2.5ppt every $100 million in synergies. - Two dec points only.

Under Scenario 1 in the Accretion / Dilution Model, 3M will use 50% debt / 50% equity. $250 million in pre-synergies were identified. Use the following assumptions in the Assumptions S1 tab of the Accretion / Dilution model: - Pre-Tax Synergies: $250mm - Control Premium: 25% - % Stock: 50% - % Debt: 50% - Interest Rate on New Debt: 8% - Fees: 1.5% of Updated Take-Private Enterprise Value - Solventum Share Price: Use the Solventum VWAP for the 75 trading days up to November 19, 2025. To calculate the price for each trading day in VWAP, use the formula (High + Low + Close) / 3 We need the Revised Accretion / Dilution percentage for 3M. Round percentages to 2 decimals points. Write back to me with your response now.

Perform a value-creation analysis based on scenario 1 using the accretion dilution model to assess whether Scenario 1 creates or destroys value for 3M Shareholders. Assumptions: 1. 3M Levered Beta is 1.15 2. Risk free rate is 4.00% 3. Equity risk premium is 5.50% 4. Calculate cost of equity using CAPM: Risk-free rate + Beta*Equity Risk Premium 5. Implied Return = SOLV Net Income/Purchase Price Paid 6. Assume Spread is calculated by Implied Return - WACC 7. For PF WACC, use 3M's existing cost of debt from Scenario 1 and assume the incremental acquisition debt carries a 10.00% interest rate (consistent with Scenario 1 assumptions). Print the output here. Format all final percentages to two decimal places.

Solventum (SOLV) announced a $2.0 billion strategic expansion funded with 70% debt and 30% equity, which caused its share price to increase by 5% relative to the closing price on 11/18/2025. Using the most recent accretion/dilution model rerun scenario 1, assuming the updated SOLV share price. Determine the revised premium 3M would pay under the updated assumptions to keep EPS accretion flat relative to the level from the original 30% premium case. Write back to me with what I requested. In the output, round the percentage to two decimal places.

In the Accretion / Dilution Model, assume stock-based compensation equals 3% of the sum of operating expenses and cost of goods sold, calculated using the model’s existing methodology, and added back to free cash flow in each forecast year. Using the “DCF-Solv” tab, provide an updated estimate of the present value of forecast-period cash flows, excluding the terminal value, under the following assumptions: - Mid-year discounting - Revenue growth of 1.0% from FY2025E through the end of the forecast period Give me figures in USD millions, rounded to two decimal places. Reply right here.

Using the 3Q 2025 3M 10Q and the accretion dilution model, calculate the following deliverables. Present all values in millions ($mm), number of shares in millions (mm), and round to whole numbers. For percentages, two decimal places. Give me the answer straight back here as a message. Base your deliverables on the following assumptions: - For the projections of 2026E cashflow available for buyback, use the extrapolation formulae (12/9 multiplication convention i.e multiply by 12/9) for specific income statement and cashflow items to convert them from nine-months ending September 2025 to full year January to December 2025. For clarity, Income statement and cashflow items on which extrapolation formulae is applied include revenue, operating expenses, depreciation & amortization, Net interest expense, Net income, cashflow from operations and CAPEX (considered as sale of property, plant and equipment). - Assume a growth rate of 5% across specific cashflow statement items calculated using extrapolation formulae for 2025E to calculate the projected cashflow statement items for the year 2026E. Consider CAPEX as sale of property, plant and equipment for the above calculation. Cashflow items on which 5% growth is applied include cashflow from operations and CAPEX. - Use 3M data in "Assumptions S2" tab for required data in the accretion dilution model for scenario 2. Calculate for me: 1. The free cash flow available for buy back in 2026E using the above assumptions by incorporating cashflow from operations and CAPEX in the formulae. 2. The buyback capacity of 3M using the Cashflow available for buy back in 2026E calculated above, minimum cash balance of $100 million, existing cash balance and proceeds from sale. 3. The number of shares that can be repurchased by 3M with this capacity. 4. The percentage reduction in shares outstanding of 3M if the company uses its entire capacity for a buyback.

If BBDC was to merge with TPVG, what would be the pro forma industry exposure for Business Services (investments at fair value as a percentage of total, based on end of September 30, 2025 data)? Use the latest 10-Q reports for each company. Consider only industry categories referring explicitly to business services in the category name. Within TPVG's combined "Business Products and Services" category, assume that only Muon is not a services provider. Present the exposure as a % to 2 decimal places. Give me my answers back in here.

Using the comps file, refine the BBDC peer set and rebuild the valuation range as of 18 Nov 2025. Use operating data for the 9M to end of 2025Q3 to derive implied prices. 1. Exclude all peers with AUM > 5,000 (values expressed in millions in the file) and exclude TSLX, GBDC, and TRIN from the peer set. 2. For the remaining peers, calculate for P/NAV, P/E, and P/Sales: 25th percentile (P25), Median, and 75th percentile (P75). 3. Derive BBDC valuation cases: Bear = P25, Base = Median, Bull = P75. 4. For each case, compute the implied equity value under each multiple, average the implied values to get the final Bear/Base/Bull equity value, and calculate % upside vs BBDC’s equity value as of 11/18/25. Output a short message with the final Bear/Base/Bull equity values and % upside for each. Give $ rounded to thousands and no decimal places, and percentages and multiples to 2 decimal places.

Recalculate "Additional paid-in capital" that factors in share buy-back of 10 million shares by BBDC. Print the answer as a reply to me here. Assume that the transaction was financed using cash on the balance sheet. Additional optional Debt is triggered only if cash drops below $10 million keeping balance sheet cash at a minimum of $10 million. Use the 9M 2025 account. Round monetary values to the nearest USD thousand.

What if BBDC change target and achieve a partial merger with FIDUS Investment Corporation (FDUS) instead of TriplePoint Venture Growth BDC Corp. (TPVG)? Use the FDUS SEC filings as of Q3 2025 and Q4 2024 to modify the 9M 2025 section of the income sheet in the merger model - Input the target share price of $19.21. Set the Financial account to "9M TTM 2025". - Assume that the BDDC / FDUS EBIT synergies will be 1.75x greater than the potential BBDC / TVPG EBIT synergies. Recalculate the pro-forma EBIT, the net investment income before tax, the net increase (decrease) in net assets from operations, and the net investment income per share. Round the net investment income per share to two decimal places. Apart from the net investment income per share, present the results rounded to USD thousands. Print your answer back here.

Consider FDUS as a potential target, use the last 6-month median share price as of 11/19/2025 in the FDUS file and the Nine Months Ended September 30 account from the FDUS 9/30 10Q. Your task is to calculate the Exchange Ratio for FDUS, % Ownership BBDC and % Ownership FDUS using the 9M 2025 account in the model using FDUS data. Give me your reply here. Round ratios to the nearest 3 decimal places, round percentage to the nearest 2 decimal places.

Calculate the accretion / dilution of both BBDC and TVPG shareholders, sensitized for different Cash consideration and Bid Premium. Edit the existing merger model and add two sensitivity analyses: one showing BBDC accretion/dilution and one showing TVPG accretion/dilution, each sensitized to bid premium (10% and 20%) and cash consideration (10% and 15%). Assume an increase of EBIT Synergies by 480bps and a 210bps decrease in post-deal bidder share price downside. All output values should be in %, rounded to 2 decimal places.

If BBDC had effectively merged with TPVG at the end of September 2025, what would be the expected synergies (in dollars) in one and a half years post-closing? You can assume the synergies equal 10% of TPVG's run-rate SG&A, income incentive fee waiver, and management and incentive fees based on the company’s financials for the quarter ended September 30, 2025, annualized, and grown at a CAGR of 5%. Please use the company's 10-Q report for the quarter ended September 30, 2025. Write your answer back to me here.

Use the BBDC valuation model as a template and a prepare a full valuation of SLR INVESTMENT CORP. (SLRC) as of FY 2024. - Use the median of peer trading multiples - Retrieve the SLRC’s required data from the attached SLRC 10K files. - Use the share price as of December 31, 2024 ($16.16) for SLRC's actual equity value. Calculate SLRC’s Implied Equity Value according to the following methods: - P / NAV, P / E, P / Sales, and NAV / Share I want you to compute the Relative Premium / (Discount) of SLRC’s actual equity value. Then, determine the lowest and highest Implied Equity Value from all the valuation methods. Round to the nearest unit for the lowest and highest Implied Equity Value in thousands dollars. Round to 2 decimal places for the Relative Premium / (Discount) results in %. Print the correct information back to me here.

Evaluate acquisition of WhiteHorse Finance (WHF) by editing the ‘Target-TPVG’ tab in merger model using WHF’s 2024 financials. Use a share price of $7.20 (as of 11/26/2025). Output two sensitivity analyses on the Post-Deal Pro Forma tab in the merger model file, showing: NAV per share (2 decimal places), NII per share accretion (%, 2 decimal places) for the WHF transaction. In each case, show analyses for: - Bid Premiums: 30% and 35%. - Cash Consideration Mix: 30% and 40%.

Assume BBDC's share to fall by 5% and TPVG's share rose by 12% post-deal and pre-issuance. The final proposed ownership split is BBDC - 75% and TPVG - 25%, maintain other assumptions constant. Create a new tab in the merger model. Calculate the "Cash Consideration", "Total Consideration", "Cash Consideration per share" and "Total Consideration per share" based on the proposed final ownership split, and the shares change Round monetary calculations to the nearest USD thousands, and round per share data to the nearest USD 2 decimal places.

To evaluate where economic value is created in the BBDC & TPVG merger, use the comps and merger models to build a four step value creation bridge. Write your reply to me here. Set the merger model to the 9M TTM 2025 account. Return the incremental change in value (%) between each scenario, the Pro Forma Implied EV after dilution, and total value creation vs standalone % (all to 2 decimal places). Here are the Scenarios: - 1. BBDC Standalone Implied Equity Value based on LTM NAV, LTM NII, and LTM Sales from the valuation model and median P/NAV, P/E, and P/S multiples on all comps from the comps file; - 2. Standalone + Synergies Implied Equity Value using run-rate synergies from the merger model; - 3. Add TPVG NAV Contribution (Pre-Dilution) using TPVG’s standalone NAV from the merger model; - 4. Pro Forma Implied Equity Value (After Dilution) using PF NAV, PF NII, PF Sales, and PF shares from the merger model.

Use "Comp Analysis – Modify" as a clean version of Comp Analysis. Replace peers WhiteHorse Finance (WHF) and TriplePoint Venture Growth BDC corps. (TPVG) and replace with SLR Investment Corp. (SLRC), Gladstone Capital (GLAD) and Stellus Capital Investment Corp (SCM). Use the attached SEC filings to complete the task. Retrieve the AUM, NAV / Share and Debt / Equity as of September 30, 2025, to complete the analysis. Calculate the mean and median for each key metrics considering BDCs with a Market Cap in the $350M to $900M range only. Get your answer back to me right here. Present the AUM in $M. All the final numbers must be rounded to 2 decimal places.

Assume that TVPG raised additional $70 million mezzanine capital ($30 million - equity capital raise from it's current shareholders at a discounted issue price of $6.0 per share and $40 million - debt capital raise at 6% interest rate), and the merger uses 50% cash consideration. Task: Using the 9M TTM 2025 account, recalculate the "Pro Forma Debt" and "Pro Forma Combined Equity Value". Print both values back in your reply. - Assume end of financial year is December 31st, debt issued date was March 31, 2025 - There are zero fees associated with the issues - Round all monetary values to the nearest USD thousand.

Using the merger model, assume BBDC's share price falls by 15% after deal announcement but before the new share issuance to TPVG shareholders. Using the 9M TTM 2025 financial account, calculate the revised pro forma balance sheet. Send me a reply with the following pro forma balance sheet line items: Total assets, Total liabilities, Total net assets, Total liabilities and net assets and Nav per share All dollar values in $’000 (whole numbers), except for NAV per share which should be rounded to two decimal places.

Using the merger model, recalculate the post-deal pro forma balance sheet in the “Post-Deal Proforma” tab under the following assumptions: - 50% cash consideration - 20% of balance sheet cash is used in the transaction - BBDC share price declines by 5% post-deal - New shares are issued at the updated (post-decline) share price Print back for me here: 1. Pro forma NAV per share 2. Pro forma Debt-to-Equity ratio Round both the per-share figure and the ratio to two decimal places.

Assume that TVPG raised additional $70 million mezzanine capital ($30 million - equity capital raise from it's current shareholders at a discounted issue price of $6.0 per share and $40 million - debt capital raise at 6% interest rate), and the merger uses 50% cash consideration financed with 80% of cash on balance sheet - Using the 9M TTM 2025 account, recalculate the "Exchange Ratio for TVPG Shareholders", "% Value Accretion/(Dilution) to BBDC shareholders", and "% Value Accretion/(Dilution) to TPVG shareholders" in the merger model and return results. Assume the end of financial year is December 31st, debt issued date was the first day of the calendar year and zero fees associated with the issues. Round all percentage calculations to the nearest 2 decimal places, and round ratio to the nearest 3 decimal places. Respond with the information in a message.